Impact of pretransplant veriables on survival. FISH karyotype (A-B), donor match (SIB, sibling donor; WMUD, well-matched unrelated donor; PMUD, partially matched unrelated donors; panels C-D), disease status at SCT (E-F), and conditioning regimen (TCD, fludarabine/cyclophosphamide/total body irradiation/in vivo alemtuzumab T-cell depletion; FC, fludarabine/cyclophosphamide; and FBC, fludarabine/busulfan/cyclophosphamide, panels G-H).